![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB |
| Item Type: | Review |
|---|---|
| Title: | Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease |
| Creators Name: | Andersen, O.M., Rudolph, I.M. and Willnow, T.E. |
| Abstract: | Alzheimer's disease (AD) represents one of the most dramatic threats to healthy aging and devising effective treatments for this devastating condition remains a major challenge in biomedical research. Much has been learned about the molecular concepts that govern proteolytic processing of the amyloid precursor protein to amyloid-{beta} peptides (A{beta}), and how accelerated accumulation of neurotoxic A{beta} peptides underlies neuronal cell death in rare familial but also common sporadic forms of this disease. Out of a plethora of proposed modulators of amyloidogenic processing, one protein emerged as a key factor in AD pathology, a neuronal sorting receptor termed SORLA. Independent approaches using human genetics, clinical pathology, or exploratory studies in animal models all converge on this receptor that is now considered a central player in AD-related processes by many. This review will provide a comprehensive overview of the evidence implicating SORLA-mediated protein sorting in neurodegenerative processes, and how receptor gene variants in the human population impair functional receptor expression in sporadic but possibly also in autosomal-dominant forms of AD. |
| Keywords: | Alzheimer Disease, Animal Disease Models, Genetic Variation, LDL-Receptor Related Proteins, Membrane Transport Proteins, Risk Factors, Animals |
| Source: | Acta Neuropathologica |
| ISSN: | 0001-6322 |
| Publisher: | Springer |
| Volume: | 132 |
| Number: | 5 |
| Page Range: | 653-665 |
| Date: | November 2016 |
| Official Publication: | https://doi.org/10.1007/s00401-016-1615-4 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
